Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies
Authors:
Open Access
- 21 October 2021
- journal article
- review article
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 8 (1) , e000739
Abstract
Background COVID-19 continues to pose a significant healthcare challenge throughout the world. Comorbidities including diabetes and hypertension are associated with a significantly higher mortality risk. However, the effect of cirrhosis on COVID-19 outcomes has yet to be systematically assessed. Objectives To assess the reported clinical outcomes of patients with cirrhosis who develop COVID-19 infection. Design/Method PubMed and EMBASE databases were searched for studies included up to 3 February 2021. All English language primary research articles that reported clinical outcomes in patients with cirrhosis and COVID-19 were included. The study was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The risk of bias was assessed using the Quality In Prognostic Score (QUIPS) risk-of-bias assessment instrument for prognostic factor studies template. Meta-analysis was performed using Cochrane RevMan V.5.4 software using a random effects model. Results 63 studies were identified reporting clinical outcomes in patients with cirrhosis and concomitant COVID-19. Meta-analysis of cohort studies which report a non-cirrhotic comparator yielded a pooled mortality OR of 2.48 (95% CI: 2.02 to 3.04). Analysis of a subgroup of studies reporting OR for mortality in hospitalised patients adjusted for significant confounders found a pooled adjusted OR 1.81 (CI: 1.36 to 2.42). Conclusion Cirrhosis is associated with an increased risk of all-cause mortality in COVID-19 infection compared to non-cirrhotic patients. Patients with cirrhosis should be considered for targeted public health interventions to prevent COVID-19 infection, such as shielding and prioritisation of vaccination.Keywords
This publication has 67 references indexed in Scilit:
- Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern ItalyJournal of Hepatology, 2020
- Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network StudyGastroenterology, 2020
- Emergency endoscopic variceal band ligation in a COVID‐19 patient presented with hematemesis while on mechanical ventilationDigestive Endoscopy, 2020
- Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort studyGut, 2020
- Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)Liver International, 2020
- Data Sharing Through the Lens of the New England Journal of Medicine.2020
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014
- Altered profile of human gut microbiome is associated with cirrhosis and its complicationsJournal of Hepatology, 2014
- Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining PrognosisGastroenterology, 2010
- Evaluation of the Quality of Prognosis Studies in Systematic ReviewsAnnals of Internal Medicine, 2006